BANK VONTOBEL/CALL/MEDTRONIC/94/0.1/20.09.24 Share Price

Warrant

DE000VM729V0

Market Closed - Boerse Frankfurt Warrants 11:25:10 28/06/2024 pm IST
0.006 EUR -40.00% Intraday chart for BANK VONTOBEL/CALL/MEDTRONIC/94/0.1/20.09.24
1 month-81.82%
3 months-97.38%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/24/28 0.006 -40.00%
27/24/27 0.01 +25.00%
26/24/26 0.008 -27.27%
25/24/25 0.011 -26.67%
24/24/24 0.015 -6.25%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 11:25 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Vontobel Vontobel
WKN VM729V
ISINDE000VM729V0
Date issued 05/01/2024
Strike 94 $
Maturity 20/09/2024 (82 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.4
Lowest since issue 0.006
Delta0.06x
Omega 22.27
Premium19.7x
Gearing367.41x
Moneyness 0.8373
Difference Strike 15.29 $
Difference Strike %+16.27%
Spread 0.01
Spread %40.00%
Theoretical value 0.0200
Implied Volatility 22.68 %
Total Loss Probability 95.11 %
Intrinsic value 0.000000
Present value 0.0200
Break even 94.21 €
Theta-0x
Vega0x
Rho0x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.71 USD
Average target price
94.02 USD
Spread / Average Target
+19.46%
Consensus